The significant immune escape of pseudotyped SARS-CoV-2 Variant Omicron
Li Zhang etl
Accepted author version
Summary
The emergence of Omicron has brought new challenges to fight against SARS-CoV-2. A large number of mutations in the Spike protein suggest that its susceptibility to immune protection elicited by the existing COVID-19 infection and vaccines may be altered. In this study, we constructed the pseudotyped SARS-CoV-2 variant Omicron. The sensitivity of 28 serum samples from COVID-19 convalescent patients infected with SARS-CoV-2 original strain was tested against pseudotyped Omicron as well as the other viruses of concern (VOCs, Alpha, Beta, Gamma, Delta) and viruses of interest (VOIs, Lambda, Mu). Our results indicated that the mean neutralization ED50 of these sera against Omicron decreased to 66,which is about 8.4 folds compared to the D614G reference strain (ED50 = 556), whereas the neutralization activity of other VOC and VOI pseudotyped viruses decreased only about 1.2-4.5 folds. The finding from our in vitro assay suggest that Omicron variant may lead to more significant escape from immune protection elicited by previous SARS-CoV-2 infection and perhaps even by existing COVID-19 vaccines.
- Forums
- ASX - By Stock
- BIT
- HIV, SA variant and BIT225
HIV, SA variant and BIT225, page-451
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.1¢ | 2.4¢ | 2.1¢ | $13.11K | 595.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3953 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 262553 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3953 | 0.023 |
2 | 316363 | 0.022 |
1 | 145000 | 0.021 |
13 | 812211 | 0.020 |
12 | 2105201 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 234917 | 2 |
0.025 | 250000 | 2 |
0.026 | 53847 | 1 |
0.027 | 162000 | 2 |
0.029 | 316026 | 1 |
Last trade - 14.45pm 21/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online